Virology

Harvard-affiliated researchers have discovered a form of double-stranded RNA which may be a potent antiviral.

In a small phase 1 trial of a herpes-based cancer therapy, one patient had their tumors completely eliminated.

Does COVID somehow weaken the immune system to make us more prone to other infectious diseases? Here's what scientists know.

Researchers are working to get a more complete understanding of the cells and antibodies behind long COVID.

When Mars samples arrive, they may carry more than knowledge. To offset the chance of a Martian pandemic, NASA is learning to contain a Red Planet plague.

Using modified mouse models originally designed for HIV, researchers have discovered an antibody that stops all known strains of COVID-19.

Due to HIV-1's extraordinary diversity, a vaccine needs to induce antibodies that can target many different strains.

The FDA has authorized Pfizer-BioNTech’s and Moderna’s updated COVID-19 boosters, which target the now-dominant Omicron subvariants.

All currently licensed COVID-19 vaccines target the spike protein’s S1 region, which is prone to mutations. We need a universal vaccine.

Researchers have created a cocktail of viruses that may be able to treat inflammatory bowel diseases like Crohn’s.